151 related articles for article (PubMed ID: 15870175)
1. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.
Ishitsuka K; Hideshima T; Hamasaki M; Raje N; Kumar S; Hideshima H; Shiraishi N; Yasui H; Roccaro AM; Richardson P; Podar K; Le Gouill S; Chauhan D; Tamura K; Arbiser J; Anderson KC
Blood; 2005 Sep; 106(5):1794-800. PubMed ID: 15870175
[TBL] [Abstract][Full Text] [Related]
2. Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).
Chauhan D; Neri P; Velankar M; Podar K; Hideshima T; Fulciniti M; Tassone P; Raje N; Mitsiades C; Mitsiades N; Richardson P; Zawel L; Tran M; Munshi N; Anderson KC
Blood; 2007 Feb; 109(3):1220-7. PubMed ID: 17032924
[TBL] [Abstract][Full Text] [Related]
3. A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma.
Chauhan D; Singh AV; Aujay M; Kirk CJ; Bandi M; Ciccarelli B; Raje N; Richardson P; Anderson KC
Blood; 2010 Dec; 116(23):4906-15. PubMed ID: 20805366
[TBL] [Abstract][Full Text] [Related]
4. Recent advances of honokiol：pharmacological activities, manmade derivatives and structure-activity relationship.
Li X; Yuan Z; Wang Y; Wang W; Shi J
Eur J Med Chem; 2024 Jun; 272():116471. PubMed ID: 38704945
[TBL] [Abstract][Full Text] [Related]
5. Honokiol-Inspired Analogs as Inhibitors of Oral Bacteria.
Solinski AE; Ochoa C; Lee YE; Paniak T; Kozlowski MC; Wuest WM
ACS Infect Dis; 2018 Feb; 4(2):118-122. PubMed ID: 29236466
[TBL] [Abstract][Full Text] [Related]
6. Preparation of honokiol-loaded titanium dioxide nanotube drug delivery system and its effect on CAL-27 cells.
Tang K; Su H; Qu Z
Front Bioeng Biotechnol; 2023; 11():1249349. PubMed ID: 37600298
[No Abstract] [Full Text] [Related]
7. Nanotechnology-Based Drug Delivery Systems for Honokiol: Enhancing Therapeutic Potential and Overcoming Limitations.
Yang J; Shang J; Yang L; Wei D; Wang X; Deng Q; Zhong Z; Ye Y; Zhou M
Int J Nanomedicine; 2023; 18():6639-6665. PubMed ID: 38026538
[TBL] [Abstract][Full Text] [Related]
8. Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma.
Ezzeldeen Y; Swidan S; ElMeshad A; Sebak A
Int J Nanomedicine; 2021; 16():5693-5712. PubMed ID: 34465990
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity.
Pan J; Lee Y; Cheng G; Zielonka J; Zhang Q; Bajzikova M; Xiong D; Tsaih SW; Hardy M; Flister M; Olsen CM; Wang Y; Vang O; Neuzil J; Myers CR; Kalyanaraman B; You M
iScience; 2018 May; 3():192-207. PubMed ID: 30428319
[TBL] [Abstract][Full Text] [Related]
10. Honokiol suppresses mycelial growth and reduces virulence of Botrytis cinerea by inducing autophagic activities and apoptosis.
Ma D; Cui X; Zhang Z; Li B; Xu Y; Tian S; Chen T
Food Microbiol; 2020 Jun; 88():103411. PubMed ID: 31997759
[TBL] [Abstract][Full Text] [Related]
11. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
[TBL] [Abstract][Full Text] [Related]
12. Honokiol exerts dual effects on browning and apoptosis of adipocytes.
Lone J; Yun JW
Pharmacol Rep; 2017 Dec; 69(6):1357-1365. PubMed ID: 29136581
[TBL] [Abstract][Full Text] [Related]
13. Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.
Yeh PS; Wang W; Chang YA; Lin CJ; Wang JJ; Chen RM
Cancer Lett; 2016 Jan; 370(1):66-77. PubMed ID: 26454217
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis.
Sheu ML; Chiang CK; Tsai KS; Ho FM; Weng TI; Wu HY; Liu SH
Free Radic Biol Med; 2008 Jun; 44(12):2043-50. PubMed ID: 18423412
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of tumor suppressor PIAS3 by Honokiol promotes tumor cell apoptosis via selective inhibition of STAT3 tyrosine 705 phosphorylation.
Fei Y; Zhang X; Wang X; Sun Y; He J; Liu X; Song Z; Li L; Qiu L; Qian Z; Zhou S; Liu X; Zhang H; Wang X
J Nat Med; 2024 Mar; 78(2):285-295. PubMed ID: 38082192
[TBL] [Abstract][Full Text] [Related]
17. Natural product piperlongumine inhibits proliferation of oral squamous carcinoma cells by inducing ferroptosis and inhibiting intracellular antioxidant capacity.
Wang ZQ; Li YQ; Wang DY; Shen YQ
Transl Cancer Res; 2023 Oct; 12(10):2911-2922. PubMed ID: 37969394
[TBL] [Abstract][Full Text] [Related]
18. The mechanisms of action of mitochondrial targeting agents in cancer: inhibiting oxidative phosphorylation and inducing apoptosis.
Yang Y; An Y; Ren M; Wang H; Bai J; Du W; Kong D
Front Pharmacol; 2023; 14():1243613. PubMed ID: 37954849
[TBL] [Abstract][Full Text] [Related]
19. Honokiol Microemulsion Causes Stage-Dependent Toxicity Via Dual Roles in Oxidation-Reduction and Apoptosis through FoxO Signaling Pathway.
Li H; Li W; Li J; Li S; Kuang L; Pang F; Jiang H; Jin H; Bian X
Cells; 2022 Nov; 11(22):. PubMed ID: 36428991
[TBL] [Abstract][Full Text] [Related]
20. Novel Delivery Systems of Polyphenols and Their Potential Health Benefits.
Enaru B; Socaci S; Farcas A; Socaciu C; Danciu C; Stanila A; Diaconeasa Z
Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
